-
1
-
-
0032533159
-
Arginine metabolism: Nitric oxide and beyond
-
Wu G, Morris SM, Jr. Arginine metabolism: nitric oxide and beyond. Biochem J 1998; 336: 1-17.
-
(1998)
Biochem J
, vol.336
, pp. 1-17
-
-
Wu, G.1
Morris Jr., S.M.2
-
3
-
-
0022621388
-
Arginine: Biochemistry, physiology, and therapeutic implications
-
Barbul A. Arginine: biochemistry, physiology, and therapeutic implications. JPENJ Parenter Enteral Nutr 1986; 10: 227-38.
-
(1986)
JPENJ Parenter Enteral Nutr
, vol.10
, pp. 227-238
-
-
Barbul, A.1
-
6
-
-
0036402941
-
Regulation of enzymes of the urea cycle and arginine metabolism
-
Morris SM, Jr. Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr 2002; 22: 87-105.
-
(2002)
Annu Rev Nutr
, vol.22
, pp. 87-105
-
-
Morris Jr., S.M.1
-
7
-
-
0030959249
-
Argininosuccinate synthetase overexpression in vascular smooth muscle cells potentiates immunostimulant-induced NO production
-
Xie L, Gross SS. Argininosuccinate synthetase overexpression in vascular smooth muscle cells potentiates immunostimulant-induced NO production. J Biol Chem 1997; 272: 16624-30.
-
(1997)
J Biol Chem
, vol.272
, pp. 16624-16630
-
-
Xie, L.1
Gross, S.S.2
-
8
-
-
2442618330
-
Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells
-
Goodwin BL, Solomonson LP, Eichler DC. Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells. J Biol Chem 2004; 279: 18353-60.
-
(2004)
J Biol Chem
, vol.279
, pp. 18353-18360
-
-
Goodwin, B.L.1
Solomonson, L.P.2
Eichler, D.C.3
-
9
-
-
0035016176
-
Regulatory role of arginase I and II in syntheses of nitric oxide, polyamines and proline in endothelial cells
-
Li H, Meininger CJ, Hawker JR, Jr et al. Regulatory role of arginase I and II in syntheses of nitric oxide, polyamines and proline in endothelial cells. Am J Physiol 2001; 280: E75-E82.
-
(2001)
Am J Physiol
, vol.280
-
-
Li, H.1
Meininger, C.J.2
Hawker Jr., J.R.3
-
10
-
-
0028846979
-
Impaired arginine metabolism and NO synthesis in coronary endothelial cells of the spontaneously diabetic BB rat
-
Wu G, Meininger CJ. Impaired arginine metabolism and NO synthesis in coronary endothelial cells of the spontaneously diabetic BB rat. Am J Physiol 1995; 269: H1312-18.
-
(1995)
Am J Physiol
, vol.269
-
-
Wu, G.1
Meininger, C.J.2
-
11
-
-
0037231551
-
Adverse effects of supplemental L-arginine in atherosclerosis - Consequences of methylation stress in a complex catabolism?
-
Loscalzo J. Adverse effects of supplemental L-arginine in atherosclerosis - consequences of methylation stress in a complex catabolism? Arterioscler Thromb Vasc Biol 2003; 23: 3-5.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 3-5
-
-
Loscalzo, J.1
-
12
-
-
4744367469
-
L-arginine and atherothrombosis
-
Loscalzo J. L-arginine and atherothrombosis. J Nutr 2004; 134: 2798S-800S.
-
(2004)
J Nutr
, vol.134
-
-
Loscalzo, J.1
-
13
-
-
0033744268
-
Arginine nutrition and cardiovascular function
-
Wu G, Meininger CJ. Arginine nutrition and cardiovascular function. J Nutr 2000; 130: 2626-29.
-
(2000)
J Nutr
, vol.130
, pp. 2626-2629
-
-
Wu, G.1
Meininger, C.J.2
-
16
-
-
4744355192
-
Enzymes of arginine metabolism
-
Morris SM, Jr. Enzymes of arginine metabolism. J Nutr 2004; 134: 2743S-47S.
-
(2004)
J Nutr
, vol.134
-
-
Morris Jr., S.M.1
-
17
-
-
1642465558
-
Arginases I and II: Do their functions overlap?
-
Cederbaum SD, Yu H, Grody WW, Kern RM, Yoo P, Iyer RK. Arginases I and II: do their functions overlap? Mol Genet Metab 2004; 81(suppl 1): S38-S44.
-
(2004)
Mol Genet Metab
, vol.81
, Issue.SUPPL. 1
-
-
Cederbaum, S.D.1
Yu, H.2
Grody, W.W.3
Kern, R.M.4
Yoo, P.5
Iyer, R.K.6
-
18
-
-
0038166375
-
Arginine availability, arginase, and the immune response
-
Bansal V, Ochoa JB. Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care 2003; 6: 223-28.
-
(2003)
Curr Opin Clin Nutr Metab Care
, vol.6
, pp. 223-228
-
-
Bansal, V.1
Ochoa, J.B.2
-
20
-
-
4744338284
-
Arginine and endothelial and vascular health
-
discussion 2895S
-
Gornik HL, Creager MA. Arginine and endothelial and vascular health. J Nutr 2004; 134: 288OS-87S; discussion 2895S.
-
(2004)
J Nutr
, vol.134
-
-
Gornik, H.L.1
Creager, M.A.2
-
21
-
-
0002996309
-
Relationship between arginase activity and nitric oxide production
-
Ignarro LJ ed. San Diego, CA: Academic Press
-
Mori M, Gotoh T. Relationship between arginase activity and nitric oxide production. In: Ignarro LJ ed. Nitric oxide: biology and pathology. San Diego, CA: Academic Press, 2000: 199-208.
-
(2000)
Nitric Oxide: Biology and Pathology
, pp. 199-208
-
-
Mori, M.1
Gotoh, T.2
-
22
-
-
0343551110
-
G-hydroxyarginine during high-output nitric oxide production
-
G-hydroxyarginine during high-output nitric oxide production. Am J Physiol 1996; 271: H1988-98.
-
(1996)
Am J Physiol
, vol.271
-
-
Buga, G.M.1
Singh, R.2
Pervin, S.3
-
23
-
-
0035347173
-
Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide-mediated vasodilatory function
-
Zhang C, Hein TW, Wang W, Chang CI, Kuo L. Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide-mediated vasodilatory function. FASEB J 2001; 15: 1264-66.
-
(2001)
FASEB J
, vol.15
, pp. 1264-1266
-
-
Zhang, C.1
Hein, T.W.2
Wang, W.3
Chang, C.I.4
Kuo, L.5
-
24
-
-
3242678848
-
Arginase pathway in human endothelial cells in pathophysiological conditions
-
Bachetti T, Comini L, Francolini G et al. Arginase pathway in human endothelial cells in pathophysiological conditions. J Mol Cell Cardiol 2004; 37: 515-23.
-
(2004)
J Mol Cell Cardiol
, vol.37
, pp. 515-523
-
-
Bachetti, T.1
Comini, L.2
Francolini, G.3
-
25
-
-
0142023863
-
Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels
-
Berkowitz DE, White R, Li D et al. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 2003; 108: 2000-2006.
-
(2003)
Circulation
, vol.108
, pp. 2000-2006
-
-
Berkowitz, D.E.1
White, R.2
Li, D.3
-
26
-
-
9444220218
-
Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension
-
Xu W, Kaneko Fr, Zheng S et al. Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J 2004; 18: 1746-48.
-
(2004)
FASEB J
, vol.18
, pp. 1746-1748
-
-
Xu, W.1
Kaneko, Fr.2
Zheng, S.3
-
27
-
-
9644282852
-
Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles
-
Zhang C, Hein TW, Wang W et al. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension 2004; 44: 935-43.
-
(2004)
Hypertension
, vol.44
, pp. 935-943
-
-
Zhang, C.1
Hein, T.W.2
Wang, W.3
-
29
-
-
4744365177
-
Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: Counteracting role of arginase
-
Hein TW, Zhang C, Wang W, Chang CI, Thengchaisri N, Kuo L. Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. FASEB J 2003; 17: 2328-30.
-
(2003)
FASEB J
, vol.17
, pp. 2328-2330
-
-
Hein, T.W.1
Zhang, C.2
Wang, W.3
Chang, C.I.4
Thengchaisri, N.5
Kuo, L.6
-
30
-
-
0036087140
-
Activities of arginase I and H are limiting for endothelial cell proliferation
-
Li H, Meininger CJ, Hawker JR, Jr, Kelly KA, Morris SM, Jr, Wu G. Activities of arginase I and H are limiting for endothelial cell proliferation. Am J Physiol 2002; 282: R64-R69.
-
(2002)
Am J Physiol
, vol.282
-
-
Li, H.1
Meininger, C.J.2
Hawker Jr., J.R.3
Kelly, K.A.4
Morris Jr., S.M.5
Wu, G.6
-
31
-
-
0033865650
-
IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells
-
Wei LH, Jacobs AT, Morris SM, Jr, Ignarro LJ. IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells. Am J Physiol 2000; 279: C248-56.
-
(2000)
Am J Physiol
, vol.279
-
-
Wei, L.H.1
Jacobs, A.T.2
Morris Jr., S.M.3
Ignarro, L.J.4
-
32
-
-
0035957042
-
Transforming growth factor-beta(1) stimulates L-arginine transport and metabolism in vascular smooth muscle cells: Role in polyamine and collagen synthesis
-
Durante W, Liao L, Reyna SV, Peyton KJ, Schafer AI. Transforming growth factor-beta(1) stimulates L-arginine transport and metabolism in vascular smooth muscle cells: role in polyamine and collagen synthesis. Circulation 2001; 103: 1121-27.
-
(2001)
Circulation
, vol.103
, pp. 1121-1127
-
-
Durante, W.1
Liao, L.2
Reyna, S.V.3
Peyton, K.J.4
Schafer, A.I.5
-
33
-
-
0030830714
-
Lysophosphatidylcholine regulates cationic amino acid transport and metabolism in vascular smooth muscle cells. Role in polyamine biosynthesis
-
Durante W, Liao L, Peyton KJ, Schafer AI. Lysophosphatidylcholine regulates cationic amino acid transport and metabolism in vascular smooth muscle cells. Role in polyamine biosynthesis. J Biol Chem 1997; 272: 30154-59.
-
(1997)
J Biol Chem
, vol.272
, pp. 30154-30159
-
-
Durante, W.1
Liao, L.2
Peyton, K.J.3
Schafer, A.I.4
-
34
-
-
0035979225
-
Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation
-
Wei LH, Wu G, Morris SM, Jr, Ignarro LJ. Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation. Proc Natl Acad Sci U S A 2001; 98: 9260-64.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 9260-9264
-
-
Wei, L.H.1
Wu, G.2
Morris Jr., S.M.3
Ignarro, L.J.4
-
35
-
-
0036020220
-
Expression of the liver form of arginase in erythrocytes
-
Kim PS, Iyer RK, Lu KV et al. Expression of the liver form of arginase in erythrocytes. Mol Genet Metab 2002; 76: 100-10.
-
(2002)
Mol Genet Metab
, vol.76
, pp. 100-110
-
-
Kim, P.S.1
Iyer, R.K.2
Lu, K.V.3
-
36
-
-
0033119962
-
Evidence that L-arginine is a key amino acid in sickle cell anemia - A preliminary report
-
Waugh WH, Daeschner CW, 3rd, Files BA, Gordon DW. Evidence that L-arginine is a key amino acid in sickle cell anemia - a preliminary report. Nutr Res 1999; 19: 501-18.
-
(1999)
Nutr Res
, vol.19
, pp. 501-518
-
-
Waugh, W.H.1
Daeschner III, C.W.2
Files, B.A.3
Gordon, D.W.4
-
37
-
-
0043204998
-
Arginine therapy: A new treatment for pulmonary hypertension in sickle cell disease?
-
Morris CR, Morris SM, Jr, Hagar W et al. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med 2003; 168: 63-69.
-
(2003)
Am J Respir Crit Care Med
, vol.168
, pp. 63-69
-
-
Morris, C.R.1
Morris Jr., S.M.2
Hagar, W.3
-
38
-
-
21444441271
-
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension and mortality in sickle cell disease
-
(in press)
-
Morris CR, Kato GJ, Poljakovic M et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension and mortality in sickle cell disease. JAMA 2005 (in press).
-
(2005)
JAMA
-
-
Morris, C.R.1
Kato, G.J.2
Poljakovic, M.3
-
39
-
-
31344445624
-
Elevated arginase activity and limited arginine availability: A common feature in asthma and sickle cell disease
-
[Abstract]
-
Morris CR, Kuypers FA, Poljakovic M et al. Elevated arginase activity and limited arginine availability: a common feature in asthma and sickle cell disease [Abstract]. Nitric Oxide 2004; 11: 112.
-
(2004)
Nitric Oxide
, vol.11
, pp. 112
-
-
Morris, C.R.1
Kuypers, F.A.2
Poljakovic, M.3
-
40
-
-
2542490292
-
Evidence for a metabolic shift of arginine metabolism in sickle cell disease
-
Schnog JJ, Jager EH, Van Der Dijs FP et al. Evidence for a metabolic shift of arginine metabolism in sickle cell disease. Ann Hematol 2004; 83: 371-75.
-
(2004)
Ann Hematol
, vol.83
, pp. 371-375
-
-
Schnog, J.J.1
Jager, E.H.2
Van Der Dijs, F.P.3
-
41
-
-
0033192865
-
Long-term outcome of short bowel syndrome in adult and pediatric patients
-
Wasa M, Takagi Y, Sando K, Harada T, Okada A. Long-term outcome of short bowel syndrome in adult and pediatric patients. JPEN J Parenter Enteral Nutr 1999; 23: S110-12.
-
(1999)
JPEN J Parenter Enteral Nutr
, vol.23
-
-
Wasa, M.1
Takagi, Y.2
Sando, K.3
Harada, T.4
Okada, A.5
-
42
-
-
0034464238
-
Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans
-
Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000; 119: 1496-505.
-
(2000)
Gastroenterology
, vol.119
, pp. 1496-1505
-
-
Crenn, P.1
Coudray-Lucas, C.2
Thuillier, F.3
Cynober, L.4
Messing, B.5
-
43
-
-
12244252221
-
Plasma urea-cycle-related amino acids, ammonium levels, and urinary orotic acid excretion in short-bowel patients managed with an oral diet
-
Pita AM, Wakabayashi Y, Femandez-Bustos MA et al. Plasma urea-cycle-related amino acids, ammonium levels, and urinary orotic acid excretion in short-bowel patients managed with an oral diet. Clin Nutr 2003; 22: 93-98.
-
(2003)
Clin Nutr
, vol.22
, pp. 93-98
-
-
Pita, A.M.1
Wakabayashi, Y.2
Femandez-Bustos, M.A.3
-
44
-
-
0031741140
-
Delayed separation and the plasma amino acids arginine and omithine
-
Nuttall KL, Chen M, Komaromy-Hiller G. Delayed separation and the plasma amino acids arginine and omithine. Ann Clin Lab Sci 1998; 28: 354-59.
-
(1998)
Ann Clin Lab Sci
, vol.28
, pp. 354-359
-
-
Nuttall, K.L.1
Chen, M.2
Komaromy-Hiller, G.3
|